Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
55.66 USD | +0.53% | -2.71% | -1.71% |
Sales 2023 by Business Segment
Sales 2023 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Pharmaceutical Products | ||||||||||
Pharmaceuticals | 26.14B | 42.52B | 46.38B | 46.16B | 45.01B | |||||
Total Assets | 130B | 118B | 109B | 96.82B | 95.16B | |||||
Interest Expense | -656M | -1.38B | -1.29B | -1.15B | -1.16B | |||||
Income Tax Expense | 1.52B | 2.12B | 1.08B | 1.37B | 400M | |||||
CAPEX | -836M | -753M | -973M | -1.12B | -1.21B | |||||
EBT | 4.98B | -6.87B | 8.1B | 7.71B | 8.44B | |||||
D&A | 1.68B | 10.43B | 10.76B | 10.28B | 9.77B | |||||
Net Income | 3.44B | -9.02B | 6.99B | 6.33B | 8.02B |
Geographical Revenue Distribution History
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
United States | 15.34B | 26.58B | 29.21B | 31.83B | 31.56B | |||||
Total Assets | 4.84B | 4.5B | 4.71B | 4.83B | 5.04B | |||||
International | - | - | - | 13.5B | 12.75B | |||||
Total Assets | - | - | - | 1.42B | 1.61B | |||||
Unallocated | 524M | 631M | 852M | 834M | 699M | |||||
Japan | - | - | - | - | - | |||||
Europe | 6.27B | 9.85B | 10.69B | - | - | |||||
Total Assets | 1.29B | 1.24B | 1.18B | - | - | |||||
Rest of The World | 4.01B | 5.46B | 5.63B | - | - | |||||
Total Assets | 126M | 142M | 163M | - | - |
- Stock Market
- Equities
- BMY Stock
- Financials Bristol-Myers Squibb Company
- Business Segments